Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

WHO

  1. Home>
  2. News>
  3. WHO>
  4. Page 4

Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

  • Post published:June 22, 2026
  • Post category:Knowledge

One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…

Continue Reading Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

  • Post published:June 21, 2026
  • Post category:News

Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…

Continue Reading Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

How to Safely Import Generic Medicines from India: A 2026 Buyer’s Guide

  • Post published:June 17, 2026
  • Post category:Knowledge

How to Safely Import Generic Medicines from India: A 2026 Buyer's Guide India supplies over 20% of the world's generic medicines by volume and 60% of global vaccine demand. For…

Continue Reading How to Safely Import Generic Medicines from India: A 2026 Buyer’s Guide

CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules

  • Post published:June 11, 2026
  • Post category:News

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is implementing one of the most ambitious regulatory overhauls in its history. In a series of coordinated actions between February…

Continue Reading CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
    September 30, 2026/
    0 Comments
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
    September 29, 2026/
    0 Comments
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
    September 28, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
  • India’s PLI Bulk Drug Push: Rs 5,210 Crore Invested by June 2026
  • CDSCO’s Digital Drug Regulatory Platform: What Buyers Should Know

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve